HAUPTMENÜ

DOC-CHECK LOGIN

Meeting highlights from the Committee for Human Medicinal Products (CHMP) 13-16 February 2012

London, UK (February 17, 2012) – This page lists the opinions adopted at the February 2012 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes.

The new format allows users to view the main opinions adopted at the meeting, along with information on referral procedures, in a clear tabular format. Users can click on the links within the page to read individual press releases and more detailed information about the opinions.

The new format replaces the two PDF documents that used to list each meeting’s outcome: the CHMP meeting highlights, published on the Friday following the meeting and the CHMP monthly report, published around a week later. The Agency will publish a new page following each month’s CHMP meeting.

Positive opinions on new medicines

Positive opinions on generics

Positive opinion on informed consent application

Positive opinions on extensions of therapeutic indications

Final opinions on safety reviews for centrally authorised medicines

Final opinions on reviews for centrally and non-centrally authorised medicines relating to manufacturing issues

Final opinions on safety reviews for centrally and non-centrally authorised medicines

Safety update

CHMP recommendation on medication errors

Other updates

European Medicines Agency, 17.02.2012 (tB).